ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the Oppenheimer MedTech, Tools, & Diagnostics Summit on May 26, 2021.
Mr. Curtis’ presentation will be available on-demand beginning at 8:00 a.m. Eastern Time on May 26, 2021 and can be accessed through the Investors section of the Company’s website at https://ir.lensar.com. The webcast will be available for two weeks after the presentation has been posted.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.
Contacts
Thomas R. Staab, II, CFO
ir.contact@lensar.com
Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
Co-CEO of The Permanente Federation and leader of multiple Permanente Medical Groups at Kaiser Permanente,…
RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical…
CHICAGO, June 12, 2025 /PRNewswire/ -- Workplace miscommunication costs businesses an estimated $1.2 trillion annually and…
Step aboard the world's largest civilian-run hospital ships and witness stories of compassion, courage, and…
JOHNSON CITY, Tenn., June 12, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central…
ROSWELL, Ga., June 12, 2025 /PRNewswire/ -- Buds Technology, a leading innovator in healthcare solutions, has…